Clinical Trial
Disease
Disease type
Hereditary retinal disease
Paediatric clinical trials
Orphan drug recognition
NA
Patient type
Adult
Children
Inclusion / Exclusion
Closing date
30/06/2018
Funding
national institution
Members involved
Main investigators
Dr Katarina Stingl
Representative
Germany
Low Vision Daily Life and Patients Groups (TWG5), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)
Working Group Leader
Others investigators
ERN EYE member investigating site
HCP : Principal investigators
Centre for Ophthalmology, University Eye Hospital, Tübingen, Germany
Adress
Department für Augenheilkunde Tübingen Forschungsinstitut für Augenheilkunde Elfriede-Aulhorn-Str. 7
72076 Tübingen
Germany